rs878854624
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_004100.5(EYA4):c.641C>A(p.Pro214Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P214P) has been classified as Likely benign.
Frequency
Consequence
NM_004100.5 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 10Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathy 1JInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004100.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EYA4 | NM_004100.5 | MANE Select | c.641C>A | p.Pro214Gln | missense | Exon 9 of 20 | NP_004091.3 | ||
| EYA4 | NM_001301013.2 | c.641C>A | p.Pro214Gln | missense | Exon 9 of 20 | NP_001287942.1 | |||
| EYA4 | NM_172105.4 | c.641C>A | p.Pro214Gln | missense | Exon 9 of 20 | NP_742103.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EYA4 | ENST00000355286.12 | TSL:1 MANE Select | c.641C>A | p.Pro214Gln | missense | Exon 9 of 20 | ENSP00000347434.7 | ||
| EYA4 | ENST00000531901.5 | TSL:2 | c.641C>A | p.Pro214Gln | missense | Exon 9 of 20 | ENSP00000432770.1 | ||
| EYA4 | ENST00000431403.3 | TSL:5 | c.572C>A | p.Pro191Gln | missense | Exon 8 of 19 | ENSP00000404558.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1J Uncertain:1
In summary, this is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a EYA4-related disease. This sequence change replaces proline with glutamine at codon 214 of the EYA4 protein (p.Pro214Gln). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and glutamine.
Cardiovascular phenotype Uncertain:1
The p.P214Q variant (also known as c.641C>A), located in coding exon 8 of the EYA4 gene, results from a C to A substitution at nucleotide position 641. The proline at codon 214 is replaced by glutamine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at